论文部分内容阅读
肿瘤是目前危害人类生命健康的重要病因。恶性肿瘤的发病死亡率仅次于心血管病而成为世界第二大死亡病因。治疗恶性肿瘤关键在于早期发现、早期诊断、早期治疗、寻找理想的检测方法成为医学界攻克的重点。福建新大陆生物技术公司引进开发的TSGF试剂盒对各类肿瘤的检测已获得巨大的突破。利用恶性肿瘤特异生长因子(TSGF)体外诊断试剂进行健康普查,并检测TSGF的特异性、敏感性、及广谱性。其方法操作简单、快速,为群体肿瘤普查、恶性肿瘤的早诊早治及良性肿瘤的鉴别提供了一个全新的手段。本文在对210例恶性肿瘤、39例良性肿瘤和114例炎症患者进行了血清学检测,同时与甲胎蛋白(APP)、癌胚抗原(CEA)、铁蛋白(FER)、糖类蛋白(CA199、CA125、CA724、CYERA211)等标志物进行了比较。肿瘤的阳性率明显高于其他肿瘤标志物的阳性率。说明肿瘤的高灵敏度可以弥补其他肿瘤标志物灵敏度不足的问题,也提示了TSGF可以作为首选的肿瘤标志物指标。
Tumor is currently an important cause of endangering human life and health. The morbidity of malignant tumors is second only to cardiovascular disease and the second leading cause of death in the world. The key to the treatment of malignant tumors is early detection, early diagnosis, early treatment, finding the ideal detection method has become the focus of the medical community to overcome. Fujian New World biotechnology companies to introduce the development of the TSGF kit detection of various types of cancer has been a huge breakthrough. The health screening was carried out by in vitro diagnostic reagent of malignant tumor specific growth factor (TSGF), and the specificity, sensitivity and broad spectrum of TSGF were tested. The method is simple and rapid, and provides a brand-new means for group cancer screening, early diagnosis and treatment of malignant tumors and identification of benign tumors. In this paper, 210 cases of malignant tumors, 39 cases of benign tumors and 114 cases of inflammation in patients with serological testing, at the same time with the AFP (APP), carcinoembryonic antigen (CEA), ferritin (FER), carbohydrate protein (CA199 , CA125, CA724, CYERA211) and other markers were compared. The positive rate of tumor was significantly higher than the positive rate of other tumor markers. The high sensitivity of the tumor can make up for the lack of sensitivity of other tumor markers, but also suggested that TSGF can be used as the first choice of tumor markers.